CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Jyväskylä Central Hospital

Academic/Hospital

Also known as: Jyväskylä Central Hospital

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Jan 31, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (5 distinct, 4 trials)

Phase 1 (1 own, 0 via acquisition)

egfrviii-specific hinge-optimized cd3 ζ-stimulatory/41bb-co-stimulatory chimeric antigen receptor autologous t-lymphocytes

Other trials (4 own, 0 via acquisition)

Recent trials (4)

NCT06210269CollaboratorN/AJan 31, 2024
NCT05063682CollaboratorPhase 1May 15, 2020
NCT03257423CollaboratorN/AApr 4, 2017
NCT03236961CollaboratorN/AApr 3, 2017

Details

Last known activity: Jan 31, 2024